Abstract
This case report describes a 44-year-old female with hepatitis C virus-related thrombocytopenia. The laboratory tests showed a platelet count of 3×109/l, positive HCV serology and high serum concentration of HCV-RNA of 6.74×106 copy/ml. She was refractory to standard therapies including corticosteroids, intravenous immunoglobulin (IVIG), thrombopoietin (TPO) and even interferon (IFN) regimens, due to the persistence of a low platelet count. At first, splenectomy was thought to be impossible, but then splenectomy was successfully performed and patient showed good tolerance and a constant normal platelet count after surgery. In conclusion, splenectomy is feasible in selected patients and may allow us to acquire a reasonable platelet count and completion of an anti-HCV protocol. Low platelet count itself should not be the contraindication of operation specifically for these patients. Further studies in larger numbers of patients and over a longer period of time are warranted.
Author supplied keywords
Cite
CITATION STYLE
Huang, X., Xie, Y., Gao, D., Shi, P., & Qian, S. (2015). Successful use of splenectomy in a patient with hepatitis c virus-related thrombocytopenia. Journal of Infection in Developing Countries, 9(7), 785–787. https://doi.org/10.3855/jidc.5084
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.